DOCSLIB.ORG

NAADAC Position Statement on Medical Marijuana Summary

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
NAADAC Position Statement on Medical Marijuana Summary INSIDE: | Prevention Messages | Advocacy in Action Recap | CE Quiz | NAADAC Annual Conference Point & Counterpoint: Medical Marijuana NAADAC NNAADAC, The Associatione for Addiction WSProfessionals We help people recover their lives. MAY | JUNE 2012 Vol. 22, No. 3 Register by June 26 to take advantage of a $50 Early Bird discount. Learn from the Best AUGUST 13 • World Class Education at the PLENARY SESSION – Healing NAADAC Conference the Addicted Brain: Cutting • Over 25 units of Continuing Edge Science and Brain Education available! Neurochemistry NAADAC has recruited the experts in 4 – 5 pm addiction prevention, treatment and Harold Urschel, III, MD, recovery to deliver a unique educational is the founder/CEO of experience. Among the thought leaders the Urschel Recovery presenting at the Leading the Way Science Institute and JW Marriott Indianapolis Conference are: Chief Medical Strategist Downtown and Co-founder of EnterHealth, an AUGUST 12 addiction disease management company based in PLENARY SESSION – Shifting from Cognitive Dallas. His innovative treatment program has been to Behavioral Approaches in CBT adopted by academic programs. 9:30 – 10:30 am Carlo DiClemente, PhD, is co-creator AUGUST 14 (with James Prochaska, PhD) of the PLENARY SESSION – The Keys to Restoring Transtheoretical Model of Change, a Intimacy in Recovery model that identifies stages of change 8:30 – 10 am and other factors that predict treatment Rokelle Lerner is a psychotherapist and outcomes and allows many more people to enter international lecturer and trainer. Shehas treatment programs at earlier stages of readiness. inspired audiences throughout the world with her ability to address difficult topics AUGUST 12 with insight, humor and astounding PLENARY SESSION – Removing Defects of clarity and has appeared as a guest consultant on Character: The Spiritual Journey Oprah, Good Morning America, CBS Morning News 4:30 – 5:15 pm and 20/20. C.C. Nuckols, PhD, is an internationally recognized expert in behavioral medicine AUGUST 15 and addictions treatment who focuses on PLENARY SESSION – What is Needed for the translating emerging scientific research Counseling Field? What is the Future of Clinical into information and techniques helpful Supervision? to those who work in addiction prevention, treat- 11 am – Noon ment and recovery. David Powell, PhD, has written books on clinical supervision that are consid- AUGUST 13 ered the primary texts in the field and he PLENARY SESSION – Chronic Pain and Addiction: served as chair of the SAMHSA Treatment A Challenging Co-occurring Disorder Improvement Protocol (TIP 52) on clinical 8:30 – 10 am supervision. Constantly in demand, he has trained in Mel Pohl, MD, FASAM, is the Medical 87 countries and all 50 US states. Director of Las Vegas Recovery Center (LVRC), a key player in developing the For full conference information Chronic Pain Recovery Program at LVRC and registration, visit and author of A Day without Pain. www.naadac.org/conferences NAADAC BOARD OF DIRECTORS NAADAC OFFICERS (updated 5/29/12) SOUTHEAST President Eddie Albright, Alabama Editor’s note Donald P. Osborn, PhD (c), LCAC Bobbie Hayes, LMHC, CAP, Florida E. Wayne Bland, MSW, LCSW, CAC II, Georgia President-Elect Albert C. Stallworth, Sr., MA, CCAP, ICAADC, Changes are coming! Robert C. Richards, MA, NCAC II, CADC III Mississippi Secretary Angela Maxwell, MS, CSAPC, North Carolina By Donovan Kuehn Roger A. Curtiss, LAC, NCAC II Cathy Jaggars, South Carolina Toby Abrams, Tennessee Treasurer Edward Olsen, LCSW, CASAC, SAP SOUTHWEST Sandy Nagy, MA, LISAC, LAC, Arizona Past President Mita Johnson, LPC, LMFT, LAC, MAC, ACS, Colorado Patricia M. Greer, BA, LCDC, AAC Mark C. Fratzke, MA, MAC, CSAC, CSAPA, Hawaii NAADAC–National Certification Commission Della Garlitz, New Mexico Chair Allen Flagg, Jr., Nevada An accepted truism of management texts and corporate leaders is James Holder III, MA, MAC, LPC, LPCS Allison Weaver, MPH, LADC, Utah Executive Director ORGANIZATIONAL REPRESENTATIVE that “the only constant is change.” That adage could be applied to Cynthia Moreno Tuohy, NCAC II, CCDC III, SAP George Joseph NAADAC right now. REGIONAL VICE PRESIDENTS PAST PRESIDENTS This will be the last hard copy edition of the NAADAC News that MID-ATLANTIC Robert Dorris (1972–1977) (Represents Delaware, the District of Columbia, Maryland , New Col. Mel Schulstad, CCDC, NCAC II (ret’d) (1977–1979) we produce. In July we will be switching to an online format to Jersey, Pennsylvania, Virginia and West Virginia) Jack Hamlin (1979–1981) Thomas Durham, PhD John Brumbaugh, MA, LSW, CADAC IV, NCAC II better reach our members. Not to worry though, you will still be (1981–1982) MID-CENTRAL Tom Claunch, CAC (1982–1986) receiving a publication from us, it will just be in the form of a new (Represents Illinois, Indiana, Kentucky, Michigan, Ohio Franklin D. Lisnow, MEd, CAC, MAC (1986–1988) and Wisconsin) Paul Lubben, NCAC II (1988–1990) NAADAC journal. We look forward to its launch this summer and the Stewart Turner-Ball Kay Mattingly-Langlois, MA, NCAC II, MAC first copies will be distributed at the NAADAC conference in MID-SOUTH (1990–1992) (Represents Arkansas, Louisiana, Oklahoma and Texas) Larry Osmonson, CAP, CTRT, NCAC II (1992–1994) Indianapolis from August 12 to 15. Greg Lovelidge, LCDC, ADC III Cynthia Moreno, NCAC I, CCDC II (1994–1996) Roxanne Kibben, MA, NCAC II (1996–1998) This issue includes an interesting debate on medical marijuana. NORTH CENTRAL T. Mark Gallagher, NCAC II (1998–2000) (Represents Iowa, Kansas, Minnesota, Missouri, Nebraska, Bill B. Burnett, LPC, MAC (2000–2002) Please read the article and take the survey to tell us what you think. North Dakota and South Dakota) Roger A. Curtiss, LAC, NCAC II (2002–2004) Diane Sevening, EdD, CDC III Mary Ryan Woods, RNC, LADC, MSHS (2004–2006) Thanks for reading, NORTHEAST Sharon Morgillo Freeman, PhD, APRN-CS, MAC (Represents Connecticut, Maine, Massachusetts, New Hampshire, (2006–2007) Donovan New York, Rhode Island and Vermont) Patricia M. Greer, BA, LCDC, AAC (2007–2010) Barbara “Bobbi” Fox, LADC, CAC NAADAC STANDING COMMITTEE CHAIRS NORTHWEST (Represents Alaska, Idaho, Oregon, Montana, Washington Bylaws Committee Chair and Wyoming) Bruce Lorenz, NCAC II, CADC Greg Bennett, MA, LAT Clinical Issues Committee Chair DEPARTMENTS FEATURES SOUTHEAST Frances Patterson, PhD, MAC (Represents Alabama, Florida, Georgia, Mississippi, North Carolina, Ethics Committee Chair South Carolina and Tennessee) Anne Hatcher, EdD, CAC III, NCAC II 14 NAADAC Position Statement: 4 LEADING THE WAY: Frances Patterson, PhD, MAC Finance Committee Chair Medical Marijuana NAADAC 2012 Annual SOUTHWEST Edward Olsen, LCSW, CASAC, SAP (Represents Arizona, California, Colorado, Hawaii, New Mexico, Conference Nevada and Utah) Nominations and Elections Chair 17 Product Review: Imagine Kirk Bowden Roberta Taggart, MA, CASAC, NCAC II Personnel Committee Chair Recovery Blends Music and 12 POINT: A Response to the BOARD OF DIRECTORS Donald P. Osborn, PhD (c), LCAC Message NAADAC Position on Medical MID-ATLANTIC NAADAC Public Policy Committee Chair Bruce Lorenz, NCAC II, CADC, Delaware Gerry Schmidt, MA, LPC, MAC Cannabis Warren E. Leggett, Jr., CAC III, CCS, District of 21 Recap: 2012 Advocacy in Columbia NAADAC AD HOC COMMITTEE CHAIRS Moe Briggs, NCC, LCPC, MAC, SAP, Maryland Action Conference 13 COUNTERPOINT: TBD, New Jersey Awards Sub-Committee Chair TBD, Pennsylvania Tricia Sapp, BSW, CCJP, CPS Legalization is Clear, Simple John Savides, CSAC, Virginia Adolescent Specialty Committee Chair 23 Continuing Education Quiz Susie Mullins, MS, LPC, ALPS, AADC-S, West Virginia Christopher Bowers, MDiv, CSAC, ASE and Wrong MID-CENTRAL International Committee Chair 24 Upcoming Events Beverly Jackson, Illinois Paul Le, BA 16 Not Your Father’s Buick: Ronald A. Chupp, LCSW, LCAC, NCAC II, ICAC II, Indiana Leadership Retention & Membership Committee Effective Prevention Michael Townsend, MSSW, Kentucky Chair Carrie Reaume, LMSW, CAAC, Michigan Roger A. Curtiss, LAC, NCAC II Messages Leon Collins, LICDC, ICADC, ICCS, Ohio Product Review Committee Chair Gerry Kaye, Wisconsin George Joseph MID-SOUTH Political Action Committee Chair TBD, Arkansas Nancy Deming, MSW, LCSW, CCAC-S TBD, Louisiana Student Committee Chair TBD, Oklahoma NAADAC NEWS Diane Sevening, EdD, CCDC II Matthew Feehery, Texas NAADAC NEWS is published bi-monthly by NAADAC, the Asso ci ation for Addic tion Pro fes sionals. National Addiction Studies and Standards NORTH CENTRAL Editor: Donovan Kuehn Layout: Elsie Smith, www.designsolutionsplus.biz Collaborative Committee Co-Chairs Randy Drake, LMHC, NCC, ACADC, MAC, Iowa Contributors to this issue: Edward A. Pane, Allan Barger, Jim Campain, Victoria Walker and Donovan Kuehn. Donald P. Osborn, PhD (c), LCAC TBD, Kansas TBD (co-chair) Images: diane39, iStockphoto.com; Dmitriy Sechin, Photospin.com; Donovan Kuehn. J.J. Johnson, Minnesota Materials in this newsletter may be reprinted, provided the source (“Re printed from NAADAC News Mar | Apr 2012”) is Alice M. Kibby, BA, LISAC, CSAC II, Missouri NALGAP, The Association of Lesbian, Gay, Jack Buehler, LADC, Nebraska Bisexual and Transgender Addiction provided. For non-NAADAC material, obtain permission from the copyright owner. Christy K. Anderson, North Dakota Professionals and Their Allies For further information about NAADAC member ship, publications, cata log and services, write: NAADAC, 1001 N. Jack Stoddard, MA, CCDC III, South Dakota Joseph M. Amico, MDiv, CAS, LISAC Fairfax Street, Suite
Load more

Recommended publications
  • Qualitative Reports of Michigan Medical Marijuana David Charles Peters Wayne State University
    Wayne State University Wayne State University Dissertations 1-1-2013 Qualitative Reports Of Michigan Medical Marijuana David Charles Peters Wayne State University, Follow this and additional works at: http://digitalcommons.wayne.edu/oa_dissertations Part of the Sociology Commons Recommended Citation Peters, David Charles, "Qualitative Reports Of Michigan Medical Marijuana" (2013). Wayne State University Dissertations. Paper 854. This Open Access Dissertation is brought to you for free and open access by DigitalCommons@WayneState. It has been accepted for inclusion in Wayne State University Dissertations by an authorized administrator of DigitalCommons@WayneState. QUALITATIVE REPORTS OF MICHIGAN MEDICAL MARIJUANA PATIENTS AND CAREGIVERS INCLUDING REDUCED OPIATE USE, DISPENSARY OPERATIONS, LEGAL CONCERNS, AND MARIJUANA STRAINS by DAVID C. PETERS II DISSERTATION Submitted to the Graduate School of Wayne State University, Detroit, Michigan in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY 2013 MAJOR: SOCIOLOGY (Medical) Approved by: ________________________________ Advisor Date ________________________________ ________________________________ ________________________________ @COPYRIGHT BY DAVID C. PETERS II 2013 All Rights Reserved DEDICATION All my work is dedicated to my wonderful children: Christopher, who grew up much too fast for this project; Andrew who was such a good little boy, playing quietly month after month, while I worked in my home office; but, especially to Katherine Joyce who left us after just five days in 2004. Katie had a very short life, but she made a difference, providing the inspiration for my return to school and showing everybody that she touched during her time on this Earth the real reason we are here: To do good works and contribute to the human condition by acquiring and disseminating knowledge, leaving a legacy of hope, and furthering the spirit of progress for our children and their children’s children.
    [Show full text]
  • War on Drugs - Wikipedia 17.08.17, 1140 War on Drugs from Wikipedia, the Free Encyclopedia
    War on Drugs - Wikipedia 17.08.17, 1140 War on Drugs From Wikipedia, the free encyclopedia "The War on Drugs" is an American term[6][7] usually applied to the United States government's campaign of prohibition of drugs, military aid, and military intervention, with the stated aim being to reduce the illegal drug trade.[8][9] This initiative includes a set of drug policies that are intended to discourage the production, distribution, and consumption of psychoactive drugs that the participating governments and the UN have made illegal. The term was popularized by the media shortly after a press conference given on June 18, 1971, by United States President Richard Nixon—the day after publication of a special message from President Nixon to As part of the War on Drugs, the US the Congress on Drug Abuse Prevention and Control—during which spends approximately $500 million per year on aid for Colombia, largely used to he declared drug abuse "public enemy number one". That message to combat guerrilla groups such as FARC the Congress included text about devoting more federal resources to that are involved in the illegal drug the "prevention of new addicts, and the rehabilitation of those who trade.[1][2][3][4][5] are addicted", but that part did not receive the same public attention as the term "war on drugs".[10][11][12] However, two years prior to this, Nixon had formally declared a "war on drugs" that would be directed toward eradication, interdiction, and incarceration.[13] Today, the Drug Policy Alliance, which advocates for an end to the
    [Show full text]
  • Drug War Madness: a Call for Consistency Amidst the Conflict Kasey C
    Chapman Law Review Volume 13 | Issue 3 Article 6 2010 Drug War Madness: A Call for Consistency Amidst the Conflict Kasey C. Phillips Follow this and additional works at: http://digitalcommons.chapman.edu/chapman-law-review Recommended Citation Kasey C. Phillips, Drug War Madness: A Call for Consistency Amidst the Conflict, 13 Chap. L. Rev. 645 (2010). Available at: http://digitalcommons.chapman.edu/chapman-law-review/vol13/iss3/6 This Article is brought to you for free and open access by the Fowler School of Law at Chapman University Digital Commons. It has been accepted for inclusion in Chapman Law Review by an authorized administrator of Chapman University Digital Commons. For more information, please contact [email protected]. Do Not Delete 8/31/2010 9:45 PM Drug War Madness: A Call for Consistency Amidst the Conflict Kasey C. Phillips* INTRODUCTION In recent weeks, months, and even years, the phrase “war on drugs” has typically been accompanied by the term “failure.” Walter Cronkite, former anchorman of the CBS evening news, noted that it is “plain for all to see: the war on drugs is a failure.”1 Similarly, Joy Olson, executive director of the Washington Office on Latin America, a human rights organization promoting democracy, stated at a drug policy conference that she “think[s] U.S. drug policy has failed.”2 Likewise, Terry Nelson, a member of Law Enforcement Against Prohibition, “considers the war on drugs to be the greatest public policy failure of all time.”3 New York Times columnist Nicholas D. Kristof asserts that, forty years after President Nixon declared the war on drugs, “it now appears that drugs have won.”4 Among the criticisms and complaints of United States drug policy are calls for reform by former international presidents,5 nonprofit organizations,6 judges,7 politicians,8 and scholars9 alike.
    [Show full text]
  • The Evolution of Popular Culture and the Legal Treatment of Marijuana
    The Chronic 2013: The Evolution of Popular Culture and the Legal Treatment of Marijuana November 12, 2013 Owen M. Panner Inn of Court 1906 - Pure Food and Drugs Act Requires Labeling of Medicine, Including Cannabis Label for Piso's Cure, a cannabis-based medicine, after the passage of the 1906 Pure Food and Drug Act Source: antiquecannabisbook.com (accessed Dec. 12, 2011) "[O]n 30 June 1906 President Roosevelt signed the Food and Drugs Act, known simply as the Wiley Act... The basis of the law rested on the regulation of product labeling rather than pre-market approval." US Food and Drug Administration (FDA) "FDA History - Part I," FDA website (accessed Dec. 28, 2011) "An Act for preventing the manufacture, sale, or transportation of adulterated or misbranded or poisonous or deleterious foods, drugs, medicines, and liquors, and for regulating traffic therein, and for other purposes... That for the purposes of this Act an article shall also be deemed to be misbranded... if the package fail to bear a statement on the label of the quantity or proportion of any alcohol, morphine, opium, cocaine, heroin, alpha or beta eucaine, chloroform, cannabis indica, chloral hydrate, or acetanilide, or any derivative or preparation of any such substances contained therein." Pure Food and Drug Act (1906) , National Center for Biotechnology Information website, June 30, 1906 Source: http://medicalmarijuana.procon.org/view.timeline.php?timelineID=000026 1911 - Massachusetts Becomes First State to Outlaw Cannabis "Bolstered by Progressive Era faith in big government, the 1910s marked a high tide of prohibitionist sentiment in America. In 1914 and 1916, alcohol prohibition initiatives would make the state ballot.
    [Show full text]
  • Decriminalization Talking Points
    Lobbying Guide Lobbying: The Basics WHAT YOU NEED TO KNOW Targeting Legislators Before you can engage with a legislator, you must first know who you are dealing with. Before you can work with your legislator, you must know where they stand on the issue and what type of legislator they are. Lobbying legislators is about persuading them to do what you want. There are five main categories of legislators to think about, and each requires its own strategy. 1. Champions All issues need a group of lawmakers dedicated to being tireless, committed advocates for your cause. What they can do for you is make the case to their colleagues, help develop a strong “inside” strategy, and be the visible spokesperson. What they need is good information, and visible support outside the capitol. 2. Allies Another group of legislators will be on your side, but can be pushed to do more-- to speak up in party caucuses or on the floor. 3. Fence Sitters Some legislators will be uncommitted on the issues, potentially able to vote either way. These legislators should be your key targets and your lobbying strategy will rely upon you putting together the right mix of “inside” persuasion and “outside” pressure to sway them your way. 4. Mellow Opponents Another group of legislators will be sure votes against you, but are not inclined to be active on your issue. With this particular group it is key to keep them from becoming more active on the issue at hand. You want to lobby them without causing them to become agitated or angry.
    [Show full text]
  • Rethinking Cannabis Legislation: Insights from Advocacy Groups Christopher Hunter Tramel University of Mississippi
    University of Mississippi eGrove Honors College (Sally McDonnell Barksdale Honors Theses Honors College) 2018 Rethinking Cannabis Legislation: Insights from Advocacy Groups Christopher Hunter Tramel University of Mississippi. Sally McDonnell Barksdale Honors College Follow this and additional works at: https://egrove.olemiss.edu/hon_thesis Part of the Sociology Commons Recommended Citation Tramel, Christopher Hunter, "Rethinking Cannabis Legislation: Insights from Advocacy Groups" (2018). Honors Theses. 203. https://egrove.olemiss.edu/hon_thesis/203 This Undergraduate Thesis is brought to you for free and open access by the Honors College (Sally McDonnell Barksdale Honors College) at eGrove. It has been accepted for inclusion in Honors Theses by an authorized administrator of eGrove. For more information, please contact [email protected]. Rethinking Cannabis Legislation: Insights from Advocacy Groups By: Christopher Hunter Tramel A thesis submitted to the faculty of The University of Mississippi in partial fulfillment of the requirements of the Sally McDonnell Barksdale Honors College. Oxford, Mississippi May 2018 Approved by ___________________________________ Advisor: Dr. Mark Frezzo Associate Professor of Sociology ___________________________________ Reader: Dr. Thomas Garrett Associate Professor of Economics ___________________________________ Reader: Dr. Joseph Holland Assistant Professor of Public Policy Leadership © 2018 Christopher Hunter Tramel ALL RIGHTS RESERVED Acknowledgements: The amount of gratitude owed from me to my family, professors, and fellow advocates is immeasurable. To approximate, I think of a quote from Isaac Newton, “If I have seen further than others, it is by standing upon the shoulders of Giants.” First, I would like to thank: my grandfather, Pappy, for being the inception to my inspiration to aspire to change the world; my parents Jim and Andrea Tramel for always believing in my efforts, no matter how lofty; my siblings, Jamie, Erik, and Emily Tramel; my advisors, Dr.
    [Show full text]
  • Drug War Madness: a Call for Consistency Amidst the Conflict Kasey C
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Chapman University Digital Commons Chapman Law Review Volume 13 | Issue 3 Article 6 2010 Drug War Madness: A Call for Consistency Amidst the Conflict Kasey C. Phillips Follow this and additional works at: http://digitalcommons.chapman.edu/chapman-law-review Recommended Citation Kasey C. Phillips, Drug War Madness: A Call for Consistency Amidst the Conflict, 13 Chap. L. Rev. 645 (2010). Available at: http://digitalcommons.chapman.edu/chapman-law-review/vol13/iss3/6 This Article is brought to you for free and open access by the Fowler School of Law at Chapman University Digital Commons. It has been accepted for inclusion in Chapman Law Review by an authorized administrator of Chapman University Digital Commons. For more information, please contact [email protected]. Do Not Delete 8/31/2010 9:45 PM Drug War Madness: A Call for Consistency Amidst the Conflict Kasey C. Phillips* INTRODUCTION In recent weeks, months, and even years, the phrase “war on drugs” has typically been accompanied by the term “failure.” Walter Cronkite, former anchorman of the CBS evening news, noted that it is “plain for all to see: the war on drugs is a failure.”1 Similarly, Joy Olson, executive director of the Washington Office on Latin America, a human rights organization promoting democracy, stated at a drug policy conference that she “think[s] U.S. drug policy has failed.”2 Likewise, Terry Nelson, a member of Law Enforcement Against Prohibition, “considers the war on drugs to be the greatest public policy failure of all time.”3 New York Times columnist Nicholas D.
    [Show full text]
  • Marijuana: a Reference Handbook, 2Nd Edition
    Marijuana Recent Titles in the CONTEMPORARY WORLD ISSUES Series Hate Crimes: A Reference Handbook, third edition Donald Altschiller Illegal Immigration: A Reference Handbook, second edition Michael C. LeMay Obesity: A Reference Handbook, second edition Judith S. Stern and Alexandra Kazaks Solar Energy: A Reference Handbook David E. Newton Prescription Drug Abuse: A Reference Handbook David E. Newton Th e Minimum Wage: A Reference Handbook Oren M. Levin-Waldman Juvenile Justice: A Reference Handbook, second edition Donald J. Shoemaker and Timothy W. Wolfe Th e Global Water Crisis: A Reference Handbook David E. Newton Youth Substance Abuse: A Reference Handbook David E. Newton Global Pandemic Th reats: A Reference Handbook Michael C. LeMay Same-Sex Marriage: A Reference Handbook, second edition David E. Newton DNA Technology: A Reference Handbook, second edition David E. Newton Modern Sport Ethics: A Reference Handbook, second edition Angela Lumpkin Books in the Contemporary World Issues series address vital issues in today’s society such as genetic engineering, pollu- tion, and biodiversity. Written by professional writers, schol- ars, and nonacademic experts, these books are authoritative, clearly written, up-to-date, and objective. Th ey provide a good starting point for research by high school and college students, scholars, and general readers as well as by legislators, business- people, activists, and others. Each book, carefully organized and easy to use, contains an overview of the subject, a detailed chronology, biographical sketches, facts and data and/or documents and other primary source material, a forum of authoritative perspective essays, annotated lists of print and nonprint resources, and an index.
    [Show full text]
  • Drug War Madness: a Call for Consistency Amidst the Conflict
    Do Not Delete 8/31/2010 9:45 PM Drug War Madness: A Call for Consistency Amidst the Conflict Kasey C. Phillips* INTRODUCTION In recent weeks, months, and even years, the phrase “war on drugs” has typically been accompanied by the term “failure.” Walter Cronkite, former anchorman of the CBS evening news, noted that it is “plain for all to see: the war on drugs is a failure.”1 Similarly, Joy Olson, executive director of the Washington Office on Latin America, a human rights organization promoting democracy, stated at a drug policy conference that she “think[s] U.S. drug policy has failed.”2 Likewise, Terry Nelson, a member of Law Enforcement Against Prohibition, “considers the war on drugs to be the greatest public policy failure of all time.”3 New York Times columnist Nicholas D. Kristof asserts that, forty years after President Nixon declared the war on drugs, “it now appears that drugs have won.”4 Among the criticisms and complaints of United States drug policy are calls for reform by former international presidents,5 nonprofit organizations,6 judges,7 politicians,8 and scholars9 alike. * J.D. 2010 Chapman University School of Law; B.S. 2007 Chapman University. I am eternally grateful for the constant love and support of my parents, Barbara and Harry Phillips, who taught me to “live the dream” and for the ever-present encouragement from my sister, Haylee Phillips. I would like to extend my undying gratitude to all of the panelists and participants in the 2010 Chapman Law Review Symposium, and to the members of the 2009-2010 Chapman Law Review Executive Board who made the symposium and this issue of the law review a reality.
    [Show full text]
  • Rethinking Cannabis Legislation: Insights from Advocacy Groups
    Rethinking Cannabis Legislation: Insights from Advocacy Groups By: Christopher Hunter Tramel A thesis submitted to the faculty of The University of Mississippi in partial fulfillment of the requirements of the Sally McDonnell Barksdale Honors College. Oxford, Mississippi May 2018 Approved by ___________________________________ Advisor: Dr. Mark Frezzo Associate Professor of Sociology ___________________________________ Reader: Dr. Thomas Garrett Associate Professor of Economics ___________________________________ Reader: Dr. Joseph Holland Assistant Professor of Public Policy Leadership © 2018 Christopher Hunter Tramel ALL RIGHTS RESERVED Acknowledgements: The amount of gratitude owed from me to my family, professors, and fellow advocates is immeasurable. To approximate, I think of a quote from Isaac Newton, “If I have seen further than others, it is by standing upon the shoulders of Giants.” First, I would like to thank: my grandfather, Pappy, for being the inception to my inspiration to aspire to change the world; my parents Jim and Andrea Tramel for always believing in my efforts, no matter how lofty; my siblings, Jamie, Erik, and Emily Tramel; my advisors, Dr. Mark Frezzo, Dr. Thomas Garrett, and Dr. Joseph Holland for staying with me through this project from beginning to end; and, lastly, my mentor, Sharon Ravert, Former Executive Director of Peachtree NORML, for lighting a fire in my heart for advocative research. Thank you all for being the Giants necessary for such a project to start, persist, and finish in my years as a student of the University of Mississippi. ABSTRACT CHRISTOPHER HUNTER TRAMEL: Rethinking Cannabis Legislation: Insights from Advocacy Groups Prohibition and regulation of substances in the United States transformed throughout the 20th century namely through the Pure Food and Drug Act, the prohibition of alcohol, the Marihuana Tax Stamp Act, and the Controlled Substances Act, with each further expanding the amount of substances regulated and the consequences of breaking the regulations.
    [Show full text]
  • Medical Marijuana: Implications of Evolving Trends in Regulation
    MEDICAL MARIJUANA: IMPLICATIONS OF EVOLVING TRENDS IN REGULATION Florence Shu-Acquaye* I. INTRODUCTION .................................................................................... 26 II. OVERVIEW OF MARIJUANA REGULATION ................................... 28 III. THE REGULATION OF MARIJUANA AS AN EVOLVING TREND ............................................................................. 30 A. Federalization Proposal ....................................................... 30 B. Social Justice as a Changing Trend ..................................... 31 1. New York ......................................................................... 31 2. New Mexico ..................................................................... 34 3. States Progressively ALLocating Marijuana ReveNues for Social Good ................................................ 34 IV. WHY LEGALIZATION DOES NOT SOLVE THE COLOR BIAS IN THE MARIJUANA INDUSTRY ............................. 36 A. Clean Criminal Record Requirement for Marijuana Retailers ....................................................... 37 B. The Banking Conundrum for Marijuana Businesses ............ 39 C. The Application Process for a License ................................. 40 D. Business Location and Public Perceptions .......................... 40 V. THE REGULATION OF MARIJUANA: THE EVOLVING TREND OF VERTICAL INTEGRATION ............................................. 41 A. Advantages of Vertical Integration ....................................... 42 B. Disadvantages of Vertical Integration ................................
    [Show full text]
  • The Role of States in Shaping the Legal Debate on Medical Marijuana Florence Shu-Acquaye
    Mitchell Hamline Law Review Volume 42 | Issue 2 Article 7 2016 The Role of States in Shaping the Legal Debate on Medical Marijuana Florence Shu-Acquaye Follow this and additional works at: http://open.mitchellhamline.edu/mhlr Part of the Criminal Law Commons, and the Criminal Procedure Commons Recommended Citation Shu-Acquaye, Florence (2016) "The Role of States in Shaping the Legal Debate on Medical Marijuana," Mitchell Hamline Law Review: Vol. 42: Iss. 2, Article 7. Available at: http://open.mitchellhamline.edu/mhlr/vol42/iss2/7 This Article is brought to you for free and open access by the Law Reviews and Journals at Mitchell Hamline Open Access. It has been accepted for inclusion in Mitchell Hamline Law Review by an authorized administrator of Mitchell Hamline Open Access. For more information, please contact [email protected]. © Mitchell Hamline School of Law Shu-Acquaye: The Role of States in Shaping the Legal Debate on Medical Marijua 7. Shu-Acquaye (697-755) (Do Not Delete) 5/2/2016 9:53 PM THE ROLE OF STATES IN SHAPING THE LEGAL DEBATE ON MEDICAL MARIJUANA Florence Shu-Acquaye† I. INTRODUCTION ...................................................................... 698 II. TRACING THE ORIGINS OF MEDICAL MARIJUANA .................. 701 A The Historical Use and Origins of Medical Marijuana around the World .............................................................. 701 B. Historical Background of the Use and Origins of Medical Marijuana in the United States ......................................... 704 1. The Marijuana Tax Act of 1937 .................................. 706 2. The Controlled Substance Act (CSA) ............................. 708 3. Drug Enforcement Agency (DEA) .................................. 710 4. The National Organization for the Reform of Marijuana Laws (NORML): Attempts to Reclassify Marijuana .................................................................
    [Show full text]